Compare ADMA Biologics Inc (ADMA) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Jones Lang LaSalle Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B). The key difference: Jones Lang LaSalle Inc is far larger — about 7.5× ADMA Biologics Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | JLL | |
|---|---|---|
Market Cap | $2.22B | $16.72B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $373.24 |
52-Week Low | $7.60 | $280.16 |
Enterprise Value | $2.29B | $19.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
